Ningbo Menovo Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603538.SS

Ningbo Menovo Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 7.73 M

Ningbo Menovo Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities is USD 7.73 M for the year ending December 31, 2023, a 129.89% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Ningbo Menovo Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -25.86 M, a -128.18% change year over year.
Ningbo Menovo Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 91.78 M, a 332.73% change year over year.
Ningbo Menovo Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 21.21 M, a 49.19% change year over year.
Ningbo Menovo Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 14.22 M, a -74.54% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shanghai Stock Exchange: 603538.SS

Ningbo Menovo Pharmaceutical Co., Ltd.

CEO	Mr. Cheng Zhi Yao
IPO Date	April 10, 2017
Location	China
Headquarters	Building1,Ningbo R&D Park
Employees	2,353
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.

Key trends

Past 5 years